Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Pruthi DK, Ankerst DP, Liss MA. Novel Definitions of Low-risk and High-risk Prostate Cancer: Implications for the European Randomized Study of Screening for Prostate Cancer Risk Assessment Tool. Eur Urol 2017;72:52-53. [DOI: 10.1016/j.eururo.2017.02.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2017] [Accepted: 02/04/2017] [Indexed: 11/26/2022]

For:	Pruthi DK, Ankerst DP, Liss MA. Novel Definitions of Low-risk and High-risk Prostate Cancer: Implications for the European Randomized Study of Screening for Prostate Cancer Risk Assessment Tool. Eur Urol 2017;72:52-53. [DOI: 10.1016/j.eururo.2017.02.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2017] [Accepted: 02/04/2017] [Indexed: 11/26/2022]

Number	Cited by Other Article(s)
1	Verbeek JF, Bangma CH, Kweldam CF, van der Kwast TH, Kümmerlin IP, van Leenders GJ, Roobol MJ. Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore. Urol Oncol 2019;37:138-144. [DOI: 10.1016/j.urolonc.2018.11.021] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2018] [Revised: 10/15/2018] [Accepted: 11/21/2018] [Indexed: 10/27/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Verbeek JF, Bangma CH, Kweldam CF, van der Kwast TH, Kümmerlin IP, van Leenders GJ, Roobol MJ. Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore. Urol Oncol 2019;37:138-144. [DOI: 10.1016/j.urolonc.2018.11.021] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2018] [Revised: 10/15/2018] [Accepted: 11/21/2018] [Indexed: 10/27/2022]